Abbott (ABT) Q1 2026 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Globe and Mail, The
Executive Vice President, Finance and Chief Financial Officer — Philip Boudreau Vice President, Investor Relations — Michael Comilla Need a quote from a Motley Fool analyst? Email pr@fool.com TAKEAWAYS Adjusted EPS -- $1.15, representing 6% growth compared to the prior year. Total Sales Growth -- 3.7% on a comparable basis, including the full-quarter impact of Exact Sciences. Full-Year Sales Growth Outlook -- 6.5%-7.5% on a comparable basis now incorporating full-year Exact Sciences results in both periods. Adjusted EPS Guidance -- Full-year midpoint revised to $5.48, reflecting $0.20 dilution from the Exact Sciences acquisition. Diagnostics Segment Performance -- Sales up 2% comparable; Core Lab Diagnostics rose 3%, while Cancer Diagnostics grew 13% and Rapid and Molecular Diagnostics declined 10% due to weak respiratory testing demand. Medical Devices Sales -- Grew 8.5%, with double-digit increases in Electrophysiology (13%), Heart Failure (12%), and Rhythm Manage
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories: This Dividend Growth King Has Rarely Been So Cheap [Seeking Alpha]Seeking Alpha
- Is Abbott (ABT) the Best Oversold Blue Chip Stock to Buy? [Yahoo! Finance]Yahoo! Finance
- Abbott Labs shares fall as earnings beat offset by Exact Sciences acquisition drag [Yahoo! Finance]Yahoo! Finance
- 1 Value Stock Worth Your Attention and 2 That Underwhelm [Yahoo! Finance]Yahoo! Finance
- What Abbott Laboratories (ABT)'s First Illinois NEC Verdict Means For Shareholders [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 4/16/26 - Form 8-K
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- ABT's page on the SEC website